MR GUIDED FOCUSED ULTRASOUND SURGERY IN PAIN MANAGEMENT DR SHRINIVAS B DESAI DR RITU K KASHIKAR JASLOK HOSPITAL AND RESEARCH CENTER MUMBAI JFIM 15 E EDITION NOV 3 RD TO 6 TH 2016
Mar 20, 2017
MR GUIDED FOCUSED ULTRASOUND SURGERY IN PAIN MANAGEMENT
DR SHRINIVAS B DESAI
DR RITU K KASHIKAR
JASLOK HOSPITAL AND RESEARCH CENTER
MUMBAI
JFIM 15E EDITION NOV 3RD TO 6TH 2016
MRGFUS What is MRgFUS?
ExAblate 2000
Clinical Applications
Clinical Research
Clinical Partners
About InSightec
Uterine Fibroids
MR guidedMR guidedF ocus edF ocus edUltras oundUltras oundS urgeryS urgery
Offeryourpatients c uttingedgetec hnology
… … … .withoutthec uttingOffers cutting edge technology without cutting
MRGFUS • Breakthrough technology that
combines
A) High intensity focused ultrasound beam that heats and destroys targeted tissue non invasively
B) MRI that visualizes patient anatomy and controls treatment by monitoring tissue effect in real time
What is MRgFUS?
ExAblate 2000
Clinical Applications
Clinical Research
Clinical Partners
About InSightec
Uterine Fibroids
How does Focused Ultrasound work?
Focused ultrasound generates heat, ablating tissue only at the focal point. The effect is similar to a magnifying glass used to focus the sun’s energy on a single point.
1x2mm
10x30mm
WaterBath
FocusedUltrasound
Beam
Tumor
T ransducer
Spot sizes
Perpendiculartobeam
Paralleltobeam
Treatment illustration
What is MRgFUS?
How does MRgFUS work
What is MRgFUS?
ExAblate 2000
Clinical Applications
Clinical Research
Clinical Partners
About InSightec
Uterine Fibroids
Why is MR guidance and control important?
3D anatomic information for exact tumor targeting
Beam path visualization for safe treatment
Real time MR thermometry to achieve planned outcome
Post treatment contrast imaging for evaluating treatment outcome
C L OS E DL OOP
THE RAPY
C L OS E DL OOP
THE RAPY=
What is MRgFUS?
What is MRgFUS?
ExAblate 2000
Clinical Applications
Clinical Research
Clinical Partners
About InSightec
Uterine Fibroids
3D anatomic views for planning treatment region
Coronal Axial Sagittal
What is MRgFUS?
What is MRgFUS?
ExAblate 2000
Clinical Applications
Clinical Research
Clinical Partners
About InSightec
Uterine Fibroids
3D beam path visualization
Surgical Clips Scars BowelSciatic Nerve
Position transducer to avoid complications:
What is MRgFUS?
Real time thermometry
Click once to view
Temperature buildup during 10 second sonication (3 second intervals)
Too cold
Too hot
100.2[C}
57.8[C]
Parameters changed based on thermal feedback
Real time MR thermometry and tissue ablation
MR thermometry demonstrates clear correlation with tissue ablation and sharp edges of sonication
Thermal dose threshold (above 240 minutes at 43° C)
Pathology of same sonication
Temperature map of a sonication
3
1 2 3
1 2
1 2 3
2 Temperature rise at margin
3 Temperature rise in untreated area, 7mm from center
1 Temperature rise at center of sonication spot
PHYSIOLOGY OF THERMAL THERAPY
Coagulated regions seen in macro pathology image
Histology analysis shows a sharp demarcation between treated and non treated regions
0.1 mm
CHRONIC LOW BACKACHE
• Chronic Low Back pain is defined as pain exceeding 3 months duration
• Low back pain or lumbago one of the commonest causes of disability and work days lost – major socioecomonic problem
• Mechanical problems including disc disease and facetal arthopathy account for approx 98 %
• 25 % of pts receiving current standard primary care remain symptomatic
FocusedUltrasoundSymposium2102,WashingtonDC,USA
FACET JOINT ANATOMY
• Facet joint = Zygoapophysial joint. • Synovial joint • Located between the superior
articular process of one vertebra and the inferior articular process of upper vertebra
FocusedUltrasoundSymposium2102,WashingtonDC,USA
FACET JOINT ARTHROPATHY
• Richinnerva+onfrommedialandlateralbranchesofdorsalramiandmedialbranchesofposteriorrami.• Degenera+onoftheFacetjointandresultantirrita+onoftheNervePlexus.
FACET JOINT ARTHROPATHY
GRADING OF DEGENERATIVE FACET JOINTS: (Gorbach et al)
0- Normal Facet joint ( 2-4 mm).
1- Narrowing of the joint < 2mm, mild osteophytes, mild hypertrophy of the articular process,
2- Moderate osteophytes, moderate hypertrophy of the articular process or mild subarticular erosions.
3- Large osteophytes, severe hypertrophy of the articular process and severe subarticular erosions.
FocusedUltrasoundSymposium2102,WashingtonDC,USA
FACET JOINT PAIN DIAGNOSIS
MBB(NERVEBLOCK)
Inj. Kanacort (40 mg), 0.5% Bupivacaine and 1% Lidocaine in 1:2:2 ratio. If the block reduces the pain by 50% , the test is considered as positive.
FocusedUltrasoundSymposium2102,WashingtonDC,USA
LUMBAR FACETAL ARTHROPATHY TREATMENT OPTIONS
INTRA-ARTICULARSTEROIDS THERMALABLATION
WITHMRgFUS
SURGICALORRADIOFREQUENCYABLATION
FocusedUltrasoundSymposium2102,WashingtonDC,USA
§ Patient population:
Ø 25 Patients in the age group 40 to 80 yrs ( Mean Age 58.6 yrs)
Ø 19 Male patients and 6 Female patients. § 10 patients underwent diagnostic injection of facet joints with a
combination of local anaesthetic and steroid injection ( Inj. Kanacort (40 mg), 1 % Lidocaine and 0.5% Bupivacaine in 1:2:2 ratio).
§ Remaining patients were included in the study on basis of the MRI features, Numerical rate scale scores(NRS) and Oswestry Disability Index (ODI).
FocusedUltrasoundSymposium2102,WashingtonDC,USA
INCLUSION CRITERIA
- Age > 40 years. - LBP due to facetal arthropathy by
- Low backache without significant Radiculopathy. - MRI - Facet joint arthropathy without significant spinal canal or neural
foraminal stenosis. - Diagnostic facet jt. injection with L.A. & steroid injection causing significant
pain reduction
- Numerical rate score (NRS) > 5. - Oswestry Disability Index(ODI) > 50%.
FocusedUltrasoundSymposium2102,WashingtonDC,USA
EXCLUSION CRITERIA
- Spinal canal stenosis
- Lumbar Radiculopathy
- Contraindications for MRI or contrast
FocusedUltrasoundSymposium2102,WashingtonDC,USA
Number of patients treated: 25 Average Numerical rate scale (NRS) score before treatment: 9 Average Numerical rate scale (NRS) score after treatment: 4 Facet joints treated: L3-L4, L4-L5, L5-S1. Number of Facet joints treated: 150 Average number of sonications: 20-25 Average duration of treatment: 1- 1.5 hrs.
TREATMENT DETAILS
FocusedUltrasoundSymposium2102,WashingtonDC,USA
TECHNICAL PARAMETERS Frequency- 0.95-2.0 MHZ Energy- 500- 700 joules Sonication duration- 20 sec Focal spots- VERTICAL AND HORIZONTAL 25mm flat, 45mm dome shaped gel pads and Waterbags. IMAGING PLANES- AXIAL SAGITTAL
FocusedUltrasoundSymposium2102,WashingtonDC,USA
TREATMENT SETUP
• MRI SUITE: GE 1.5 TESLA HDXT with EXBLATE 2000. • POSITION: FEET FIRST , SUPINE. • ANESTHESIA: MILD CONSCIOUS SEDATION (1-2 mg Midazolam and 25-50 microgram Fentanyl).
FocusedUltrasoundSymposium2102,WashingtonDC,USA
SONICATION
IMMEDIATE POST TREATMENT EVALUATION
POST TREATMENT SUBSTRACTION IMAGES
FocusedUltrasoundSymposium2102,WashingtonDC,USA
NUMERICAL RATE SCALE (NRS)SCORE
JASLOKHOSPITAL,MUMBAI
OSWESTRY DISABILITY INDEX (ODI)
JASLOKHOSPITAL,MUMBAI
BRIEF PAIN INVENTORY(BPI)
JASLOK HOSPITAL, MUMBAI
DISCUSSION Safe and effective procedure and no adverse side effects or complications were encountered.
Can be performed on out patient basis and is done with thermal monitoring. Patient selection is important.
Results comparable to Radiofrequency ablation and other techniques. Larger case study and longer follow-up will help to prove long term efficacy.
JASLOK HOSPITAL, MUMBAI FocusedUltrasoundSymposium2102,WashingtonDC,USA
MRGFUS IN FACETAL ARTHROPATHY
MRI-guided focused ultrasound (MRgFUS) to treat facet joint osteoarthritis low back pain--case series of an innovative new technique. Eighteen patients were treated. There were no major adverse events. At 6/12 we found a reduction in both the NRS (average/worst) pain scores (60.2 %/51.2 %). This was associated with 45.9 % improvement in the ODQ score and 61.9 % reduction in the BPI interference score. We observed an improvement in the EuroQol (EQ-5D) health state score based on UK coefficients of +0.379 (0.317 to 0.696).
Weeks EM, Platt MW, Gedroyc W Eur Radiol. 2012 Dec;22(12):2822-35. doi: 10.1007/s00330-012-2628-6. Epub 2012 Aug 31
MRGFUS VS RHIZOTOMY As a noninvasive form of facet rhizotomy, focused ultrasound may offer benefits including:
• no needles (anticoagulation thus not an issue)
• no ionizing radiation
• can treat several affected facet joints in one session
• real-time anatomic and thermal monitoring, which reduces the risk for complications
• shorter recovery time.
NumberofbonemetastasistreatmentsdoneatJaslokhospitalandresearchcentre:9Averagedura+onoftreatment:1-2hoursAveragenumberofsonica+ons:15-25Be[erthanradiotherapy1daytreatment
BONEMETASTASIS
CASES 74 YEAR OLD/ MALE PATIENT K/C/O CA LUNG WITH LEFT ILIAL METASTASIS PAIN IN PELVIC REGION LEFT SIDE SINCE 6 MONTHS NRS PAIN SCORE BEFORE TREATMENT: 7 NUMBER OF SONICATIONS: FIRST SESSION: 26 DURATION : 1.4 HOURS SECOND SESSION: 29 DURATION: 1.5 HOURS NRS PAIN SCORE AFTER TREATMENT: 2
PRETREATMENTPOSTCONTRASTT1WEIGHTEDIMAGE.
POST TREATMENT POST CONTRAST T1 WEIGHTED IMAGE.
JASLOKHOSPITAL,INDIA
PRETREATMENTPOSTCONTRASTT1WEIGHTEDIMAGE
POST TREATMENT POST CONTRAST T1 WEIGHTED IMAGE
NRS SCORE BEFORE MRGFUS
NRS 5 DAYS AFTER MRGFUS
PAIN PALLIATION IN PATIENTS WITH BONE METASTASES USING MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND
A total of six painful metastatic bone lesions in five patients were treated using MRgFUS with the ExAblate Conformal Bone System for pain palliation. The follow-up sessions were at 3 days, 2 weeks, 1, 2, and 3 months, and 1 year after treatment. Efficacy was evaluated by the changes in visual analog scale (VAS) scores.
MRgFUS was demonstrated to be effective palliative treatment within 2 weeks in selected patients with painful bone metastases.
Yonsei Med J. 2015 Mar 1; 56(2): 503–509.
MRGFUS OF OSTEOID OSTEOMA
PRE TREATMENT
POST TREATMENT
MRGFUS IN OSTEOARTHRITIC KNEE PAIN
• Sonication area -as the bone surface just below the rim osteophyte of medial tibia plateau, which is the insertion site of deep medial collateral ligament
• The ultrasound beam angled to avoid popliteal neurovascular bundles.
Arrow heads in MRI indicate low intensity curved line at the sonication site. Arrows in X-p indicate osteosclerotic change in accordance with the line in MRI.
MR-GUIDED FOCUSED ULTRASOUND FOR THE NOVEL AND INNOVATIVE MANAGEMENT OF OSTEOARTHRITIC KNEE PAIN
These initial results illustrate the safety and efficacy of the newly developing MRgFUS treatment. Significant increase of PPTs on treated area showed successful denervation effect on the nociceptive nerve terminals. MRgFUS is a promising and innovative procedure for noninvasive pain management of knee
BMC Musculoskelet Disord. 2013; 14: 267A.
PATHOLOGY TOTAL NUMBER
UTERINE FIBROID 1005
ADENOMYOSIS 92
FACETAL ARTHROPATHY
25
BONE METASTASIS
9
OTHER BONE TUMOURS
1
PROSTATE CANCER 7
MRgFUS EXPERIENCE AT JASLOK HOSPITAL AND RESEARCH CENTER,MUMBAI